Acerta Pharma B.V. et al v. Alembic Pharmaceuticals Limited et al
| Acerta Pharma B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB and Merck Sharp & Dohme B.V. |
| Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc. |
| 1:2023cv00548 |
| May 19, 2023 |
| US District Court for the District of Delaware |
| Gregory B Williams |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 21, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
SO ORDERED, re #9 STIPULATION TO EXTEND TIME for Alembic to answer, move or otherwise respond to the Complaint to June 28, 2023 filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 6/21/23. (ntl)
|
| Filing 9 STIPULATION TO EXTEND TIME Alembic to answer, move or otherwise respond to the Complaint to June 28, 2023 - filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc.. (Gattuso, Dominick) |
|
SO ORDERED, re (8 in 1:23-cv-00548-GBW, 98 in 1:22-cv-00154-GBW-SRF) STIPULATION and [Proposed] Order Regarding Service of Complaint Against Alembic and Case Consolidation filed by AstraZeneca Pharmaceuticals, LP, Merck Sharp & Dohme B.V., AstraZeneca UK Limited, AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Acerta Pharma B.V. Signed by Judge Gregory B. Williams on 5/30/23. Associated Cases: 1:22-cv-00154-GBW-SRF, 1:23-cv-00548-GBW (ntl)
|
| Case associated with lead case: Create association to 1:22-cv-00154-GBW-SRF. ALL PAPERS SHALL BE FILED IN LEAD CASE NO. 22-154-GBW-SRF ONLY. (ntl) |
| Filing 8 STIPULATION and [Proposed] Order Regarding Service of Complaint Against Alembic and Case Consolidation by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V., AstraZeneca Pharmaceuticals LP. (Joyce, Alexandra) |
| Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) |
| Filing 7 Summons Issued as to Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc. on 5/19/2023. (Attachments: #1 Summons Issued Alembic Pharmaceuticals, Inc.)(jfm) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co. for Merck Sharp & Dohme B.V. filed by Merck Sharp & Dohme B.V. (jfm) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, and AstraZeneca UK Limited filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited(jfm) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,272,083. (jfm) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: April 5, 2023. Date of Expiration of Patent: January 21, 2035.Thirty Month Stay Deadline: 4/30/2025. (jfm) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4140070.) - filed by AstraZeneca UK Limited, Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, Merck Sharp & Dohme B.V., and AstraZeneca AB. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(jfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
